Bromadol, a newly synthetic opioid, exhibits peculiar pharmacological characteristics. This compound primarily operates as an limited μ-opioid binding site stimulant, however shows significant activity with the kappa location as too. This combined action results to the intricate range of impacts, including pain relief, relaxation, plus potentia